10Feb
The LHD/ERISA Advisor: Sixth Circuit Rejects MSPA and ERISA Discrimination Claims
Seeking to control healthcare costs, many group health plans have adopted amendments that lower reimbursement rates for the treatment of end-stage renal disease ("ESRD"), which requires long-term dialysis treatment or a kidney transplant, resulting...
By:
Hinshaw & Culbertson LLP
Related
Over the last 18 months, a raft of publicity has propelled environmental, social and governance (ESG...
Read More >
Employers often allow employees to donate leave to co-workers who are experiencing medical emergenci...
Read More >
Here is the latest in a series of blogs about AB 51, the California bill that threatened mandatory a...
Read More >
In this period of significant market volatility and economic headwinds, risk allocation provisions i...
Read More >
Increased awareness of safety concerns related to foreign direct investments has prompted a ramp-up ...
Read More >
In today’s edition of Daily Compliance News: • Martin Shkreli Loses His Appeal (NYT) • Surprise ...
Read More >